| Synthesis, dispersion, and cytocompatibility of graphene oxide and reduced graphene oxide M Wojtoniszak, X Chen, RJ Kalenczuk, A Wajda, J Łapczuk, M Kurzewski, ... Colloids and Surfaces B: Biointerfaces 89, 79-85, 2012 | 463 | 2012 |
| Protein abundance of clinically relevant multidrug transporters along the entire length of the human intestine M Drozdzik, C Gröer, J Penski, J Lapczuk, M Ostrowski, Y Lai, B Prasad, ... Molecular pharmaceutics 11 (10), 3547-3555, 2014 | 277 | 2014 |
| Polymorphism in the P-glycoprotein drug transporter MDR1 gene: a possible link between environmental and genetic factors in Parkinson's disease M Drozdzik, M Bialecka, K Mysliwiec, K Honczarenko, J Stankiewicz, ... Pharmacogenetics and Genomics 13 (5), 259-263, 2003 | 264 | 2003 |
| Effect of quercetin on experimental hyperlipidemia and atherosclerosis in rabbits S JuŸwiak, J Wójcicki, K Mokrzycki, M Marchlewicz, M Białecka, ... Pharmacol Rep 57 (57), 604-9, 2005 | 194 | 2005 |
| Activity of essential phospholipids (EPL) from soybean in liver diseases KJ Gundermann, A Kuenker, E Kuntz, M Droździk Pharmacological Reports 63 (3), 643-659, 2011 | 180 | 2011 |
| Association of Nrf2-encoding NFE2L2 haplotypes with Parkinson's disease M von Otter, S Landgren, S Nilsson, D Celojevic, P Bergström, ... BMC medical genetics 11, 1-9, 2010 | 140 | 2010 |
| Protein abundance of clinically relevant drug‐metabolizing enzymes in the human liver and intestine: a comparative analysis in paired tissue specimens M Drozdzik, D Busch, J Lapczuk, J Müller, M Ostrowski, M Kurzawski, ... Clinical pharmacology & therapeutics 104 (3), 515-524, 2018 | 130 | 2018 |
| Effect of CYP2C19*17 gene variant on Helicobacter pylori eradication in peptic ulcer patients M Kurzawski, B Gawrońska-Szklarz, J Wrześniewska, A Siuda, ... European journal of clinical pharmacology 62, 877-880, 2006 | 126 | 2006 |
| Essential phospholipids in fatty liver: a scientific update KJ Gundermann, S Gundermann, M Drozdzik, VG Mohan Prasad Clinical and experimental gastroenterology, 105-117, 2016 | 121 | 2016 |
| Protein abundance of clinically relevant drug transporters in the human liver and intestine: a comparative analysis in paired tissue specimens M Drozdzik, D Busch, J Lapczuk, J Müller, M Ostrowski, M Kurzawski, ... Clinical Pharmacology & Therapeutics 105 (5), 1204-1212, 2019 | 116 | 2019 |
| The association of functional catechol-O-methyltransferase haplotypes with risk of Parkinson's disease, levodopa treatment response, and complications M Bialecka, M Kurzawski, G Klodowska-Duda, G Opala, EK Tan, ... Pharmacogenetics and genomics 18 (9), 815-821, 2008 | 114 | 2008 |
| Polymorphism in the P-glycoprotein drug transporter MDR1 gene in colon cancer patients M Kurzawski, M Droździk, J Suchy, G Kurzawski, M Białecka, W Górnik, ... European journal of clinical pharmacology 61, 389-394, 2005 | 113 | 2005 |
| The influence of active components of Eleutherococcus senticosus on cellular defence and physical fitness in man S Szołomicki, L Samochowiec, J Wojcicki, M Droździk Phytotherapy Research: An International Journal Devoted to Pharmacological …, 2000 | 112 | 2000 |
| Reduced folate carrier-1 80G> A polymorphism affects methotrexate treatment outcome in rheumatoid arthritis M Drozdzik, T Rudas, A Pawlik, W Gornik, M Kurzawski, M Herczynska The pharmacogenomics journal 7 (6), 404-407, 2007 | 108 | 2007 |
| Regression of colon cancer and induction of antitumor immunity by intratumoral injection of adenovirus expressing interleukin-12 G Mazzolini, C Qian, X Xie, Y Sun, JJ Lasarte, M Drozdzik, J Prieto Cancer gene therapy 6 (6), 514-522, 1999 | 107 | 1999 |
| A blood–tumor barrier limits gene transfer to experimental liver cancer: the effect of vasoactive compounds R Bilbao, M Bustos, P Alzuguren, MJ Pajares, M Drozdzik, C Qian, ... Gene therapy 7 (21), 1824-1832, 2000 | 100 | 2000 |
| Absolute protein quantification of clinically relevant cytochrome P450 enzymes and UDP-glucuronosyltransferases by mass spectrometry-based targeted proteomics C Gröer, D Busch, M Patrzyk, K Beyer, A Busemann, CD Heidecke, ... Journal of pharmaceutical and biomedical analysis 100, 393-401, 2014 | 99 | 2014 |
| The effect of 3435C>T MDR1 gene polymorphism on rheumatoid arthritis treatment with disease-modifying antirheumatic drugs M Drozdzik, T Rudas, A Pawlik, M Kurzawski, B Czerny, W Gornik, ... European journal of clinical pharmacology 62, 933-937, 2006 | 99 | 2006 |
| Expression, regulation and function of intestinal drug transporters: an update J Müller, M Keiser, M Drozdzik, S Oswald Biological chemistry 398 (2), 175-192, 2017 | 93 | 2017 |
| 677C>T and 1298A>C MTHFR polymorphisms affect methotrexate treatment outcome in rheumatoid arthritis M Kurzawski, A Pawlik, K Safranow, M Herczynska, M Drozdzik Pharmacogenomics 8 (11), 1551-1559, 2007 | 93 | 2007 |
